TESSERACT CAPRAMAX
Live / Applied — Response to non-final action entered (as of 01 Jan 2026)
What this means for you
Not registered yet, but its 13 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99391328
- Mark type
- Stylized text
- Filed
- 13 Sept 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.
Owner
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
Prior registrations
Prosecution history
- 01 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Dec 2025 — NON-FINAL ACTION E-MAILED
- 29 Dec 2025 — NON-FINAL ACTION WRITTEN
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 13 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Sept 2025 — NEW APPLICATION ENTERED